Department of Pediatric Cardiology, Baylor College of Medicine, Texas Children's Hospital, 6651 Main Street, E1920, Houston, TX, 77030, USA.
Division of Pediatric Cardiac Anesthesia, Baylor College of Medicine, Texas Children's Hospital, Houston, TX, 77030, USA.
Pediatr Cardiol. 2022 Jan;43(1):104-109. doi: 10.1007/s00246-021-02697-9. Epub 2021 Aug 7.
Pediatric cardiac interventions via percutaneous common carotid artery (CCA) access have been shown to be safe and effective. However, the impact of placement of a sheath in the carotid artery for interventions on cerebral perfusion is unknown. In this study we used cerebral near-infrared spectroscopy (NIRS) to analyze the effects of percutaneous CCA access for cardiac interventions on cerebral perfusion. This study is a retrospective chart review carried out at a tertiary care center on all pediatric patients who underwent percutaneous cardiac catheterization via carotid artery access from January 2010 to January 2020. All patients who had ipsilateral NIRS recorded on the side of carotid artery access were included. Patients with only partial or no ipsilateral NIRS data were excluded. The primary outcome measure was the change in NIRS upon CCA access; the mean NIRS for 15 min before obtaining access was compared to the mean NIRS during the procedure and to the mean NIRS 15 min after removal of the CCA sheath. We hypothesized that there would be a significant drop in NIRS values on the side of CCA access. There were 48 catheterizations in the study period where percutaneous CCA was accessed. Of those, 21 catheterizations had complete data and were included in the study. 13 (62%) were of males. The median age was 23 days (IQR 7-79). The indications for CCA access were patent ductus arteriosus stent implantation (n = 13; 62%), aortic valvuloplasty (n = 5; 24%), balloon angioplasty of coarctation of aorta (n = 2; 10%), and renal artery angioplasty (n = 1; 4%). In 16 patients (72%), the left common carotid artery was accessed. The median weight of the patients was 3.3 kg (IQR 2.8-2.9). The most common sheath size used was 4F, in 16 patients (72%). The mean NIRS prior to the procedure was 67 ± 15%, during the procedure was 68 ± 20%, and after removal of sheath was 68 ± 21%. Paired t test of cerebral NIRS before, during, and after the procedure showed no significant change with CCA access (P = 0.08). No patient in the series had a documented neurologic deficit following the procedure. Percutaneous CCA access was not associated with a decrease in NIRS on the side of the access during the procedure, suggesting there was no significant acute change in cerebral perfusion with CCA access.
经皮股总动脉(CCA)入路的儿科心脏介入已被证明是安全有效的。然而,CCA 入路放置鞘管进行介入治疗对脑灌注的影响尚不清楚。在这项研究中,我们使用近红外光谱(NIRS)分析经皮 CCA 入路进行心脏介入治疗对脑灌注的影响。这是一项在三级医疗中心进行的回顾性图表研究,纳入了 2010 年 1 月至 2020 年 1 月期间经 CCA 入路行经皮心导管术的所有儿科患者。所有接受 CCA 入路同侧 NIRS 记录的患者均被纳入研究。排除仅部分或无同侧 NIRS 数据的患者。主要观察指标为 CCA 入路时 NIRS 的变化;在获得入路前的 15 分钟内,平均 NIRS 与手术过程中的平均 NIRS 以及 CCA 鞘管移除后的 15 分钟内的平均 NIRS 进行比较。我们假设 CCA 入路侧的 NIRS 值会显著下降。在研究期间,有 48 次经皮 CCA 入路。其中,21 次导管术有完整的数据并纳入研究。13 例(62%)为男性。中位年龄为 23 天(IQR 7-79)。CCA 入路的适应证为动脉导管未闭支架植入术(n=13;62%)、主动脉瓣成形术(n=5;24%)、主动脉缩窄球囊扩张术(n=2;10%)和肾动脉血管成形术(n=1;4%)。16 例(72%)患者行左侧 CCA 入路。患者的中位体重为 3.3kg(IQR 2.8-2.9)。最常使用的鞘管尺寸为 4F,在 16 例患者(72%)中。术前平均 NIRS 为 67±15%,术中为 68±20%,术后为 68±21%。手术前、手术中和手术后大脑 NIRS 的配对 t 检验显示,CCA 入路无明显变化(P=0.08)。该系列中没有患者在手术后出现神经系统缺损的记录。经皮 CCA 入路与手术过程中入路侧 NIRS 下降无关,提示 CCA 入路对脑灌注无明显急性变化。